Loading…

OK to use analytics cookies? We measure usage without cookies either way; accepting lets us see repeat visits. Declining changes nothing about how the site works. Privacy policy

Pricing Blog About us Log in Create a free account

Directory

Every key opinion leader in the directory, every fact cited to its public source.

Showing 145–151 of 151 KOLs

Sort

Drug: Galantamine✕

Arthur Lee, MD

Basic profileCardiologyCardiovascular DiseaseWest · WA

—
publications: —
h-index: 4
companies

View profile →

Paul Rosenberg, MD

Basic profilePsychiatryPsychiatryNortheast · MD

—
publications: —
h-index: 5
companies

View profile →

Makoto Ishii, MD

Basic profileNeurologyNeurologySouth Central · TX

—
publications: —
h-index: 2
NIH grants

View profile →

Anand Viswanathan, MD, PhD

Basic profileNeurologyNeurologyNortheast · MA

—
publications: —
h-index: 4
NIH grants

View profile →

Matthew Barrett, MD

Basic profileNeurologyNeurologySoutheast · VA

—
publications: —
h-index: 2
trials

View profile →

Robert Buchanan, MD

University of Maryland School of Medicine

Enriched profilePsychiatryPsychiatryNortheast · MD

—
publications: 82
h-index: 15
trials

View profile →

Brent Forester, MD

Tufts Medical Center

Enriched profilePsychiatryGeriatric PsychiatryNortheast · MA

—
publications: 42
h-index: 11
trials

View profile →

← PrevPage 7 of 7Next →

findmyKOL

The world’s largest open source directory of pharma KOLs.

KOLs by therapeutic area

Oncology
Respiratory
Cardiology
Infectious Disease
Neurology
Rare/Genetic
Gastroenterology
Psychiatry
Endocrinology/Metabolic
Rheumatology/Immunology
Nephrology
Ophthalmology
Dermatology
Hematology
Epidemiology
All therapeutic areas →

KOLs by region

Northeast
West
Southeast
Midwest
South Central
All regions →

About

Directory
Institutions
Companies
About us
Blog
Pricing
Methodology
Sources
How we verify
Contact

© 2026 findmyKOL